Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000022705 |
|---|---|
| Receipt number | R000025658 |
| Scientific Title | A phase II study of TAS-102 plus Bevacizumab therapy for advanced/recurrent colorectal cancer with difficulty on intensive chemotherapy |
| Date of disclosure of the study information | 2016/06/12 |
| Last modified on | 2019/08/27 22:32:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/06/12 12:12:15 | ||
| 2 | Update | 2019/08/27 22:32:01 | Recruitment status Date of IRB Last follow-up date |